首页> 外文期刊>Retina >CHOROIDAL NEOVASCULARIZATION COMPLICATING PHOTODYNAMIC THERAPY FOR CENTRAL SEROUS RETINOPATHY
【24h】

CHOROIDAL NEOVASCULARIZATION COMPLICATING PHOTODYNAMIC THERAPY FOR CENTRAL SEROUS RETINOPATHY

机译:复杂性中枢性视网膜视网膜病变的脉络膜新生血管的光动力治疗

获取原文
获取原文并翻译 | 示例
       

摘要

Central serous retinopathy (CSR) is characterized by localized serous retinal detachment in the macular region due to a breakdown in the outer blood-retinal barrier (at the retinal pigment epithelium [RPE]). Patients with CSR present with visual blurring, distortion, micropsia, and a positive scotoma in the central field of vision. Most cases of CSR are self-limited, with a duration of 6 weeks to 8 weeks. However, recurrences are frequent, occurring in about one third of all patients after the first episode of the disease. Chronic and recurrent CSR can be visually disabling in these patients. Macular RPE atrophy with associated atrophic photoreceptor degeneration and (in a few cases) choroidal neovascularization (CNV) may accompany chronic and recurrent CSR.
机译:中枢性浆液性视网膜病变(CSR)的特征在于,由于外部血视网膜屏障(在视网膜色素上皮[RPE]处)的破坏,黄斑区发生了局部浆液性视网膜脱离。 CSR患者的视力中央出现视力模糊,畸变,显微活检和阳性葡萄球菌。大多数企业社会责任案例是自限性的,持续时间为6周至8周。然而,复发是频繁的,在该疾病的第一发作后约三分之一的所有患者中发生。在这些患者中,慢性和复发性CSR可能会导致视觉残疾。黄斑RPE萎缩伴有萎缩性感光细胞变性和(在少数情况下)脉络膜新生血管形成(CNV)可能伴有慢性和复发性CSR。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号